EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging Roles of Adenosine Metabolism in Astrocytes During Brain Injury

Shu Zhu, Shanshan Zhong, Xiaoru Lin, Chuansheng Zhao iD, Yugang Li iD

CNS Neuroscience & Therapeutics · 2026-05 · 32 (5)

DOI: 10.1002/cns.70889 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 15.05.2026. Verfasst von Shu Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China. Hauptthemen laut MEDLINE: Astrocytes, Adenosine, Brain Injuries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Adenosine is a key metabolic and neuroregulatory factor in the brain, and an adenosine‐rich immunosuppressive microenvironment is formed post‐stroke, making the adenosine pathway a crucial therapeutic target for improving stroke immunotherapy efficacy. This study aims to address the knowledge gaps hindering adenosine therapy translation, summarize the integrated network of extracellular and intracellular adenosine metabolism, and highlight the dynamic changes of adenosine metabolism in astrocytes and the potential of purine‐converting enzymes as therapeutic targets for cerebral ischemic stroke.

Methods

We conducted a comprehensive summary and analysis of existing research progress over the past two decades, focusing on adenosine metabolic networks (extracellular and intracellular), adenosine metabolic enzymes, subcellular compartmental metabolic pathways, dynamic changes of adenosine metabolism in astrocytes during brain injury, and the role of purine‐converting enzymes in cerebral ischemic stroke. We also reviewed the limitations of current adenosine‐related therapies (e.g., P2Y12‐targeted drugs) and existing knowledge gaps.

Results

Post‐stroke, dying and stressed neuronal cells increase ATP release, which is converted to adenosine by extracellular enzymes, forming an adenosine‐rich immunosuppressive microenvironment. P2Y receptors (a type of ADP receptor) have been extensively studied as vital drug targets for ischemic stroke, but treatments such as Ticagrelor (targeting P2Y12) are associated with severe bleeding. Key knowledge gaps include the lack of cell type‐specific regulation of the adenosine pathway in the brain and insufficient consideration of cell compartmentalized adenosine metabolism. Additionally, astrocyte adenosine metabolism undergoes dynamic changes during brain injury, and purine‐converting enzymes exhibit potential as novel therapeutic targets for cerebral ischemic stroke.

Conclusions

Adenosine metabolism forms an integrated complex network involving extracellular and intracellular processes, with distinct metabolic enzymes and subcellular compartmental pathways. Dynamic changes of adenosine metabolism in astrocytes and purine‐converting enzymes are critical for the development of adenosine‐based therapies for cerebral ischemic stroke. Addressing existing knowledge gaps (e.g., cell type‐specific regulation and compartmentalized metabolism) is essential to overcome current clinical trial difficulties and promote the translation of adenosine therapy for stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytesAdenosineBrain InjuriesHumansAnimals

Substanzen

Adenosine

Autor:innen und Institutionen

  • Department of Rehabilitation, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.
  • Department of Neurology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Liaoning Provincial Key Laboratory of Big Data for Neurological Diseases, Shenyang, Liaoning, China.
  • Department of Neurology, Stroke Center, The First Hospital of China Medical University, Shenyang, Liaoning, China.

ORCID-Profile: Chuansheng Zhao, Yugang Li

Zitieren

APA

Zhu, S., Zhong, S., Lin, X., Zhao, C., & Li, Y. (2026). Emerging Roles of Adenosine Metabolism in Astrocytes During Brain Injury. CNS Neuroscience & Therapeutics, 32(5). https://doi.org/10.1002/cns.70889

Vancouver

Zhu S, Zhong S, Lin X, Zhao C, Li Y. Emerging Roles of Adenosine Metabolism in Astrocytes During Brain Injury. CNS Neuroscience & Therapeutics. 2026;32(5). doi:10.1002/cns.70889

BibTeX
@article{Zhu2026,
  author = {Zhu, Shu and Zhong, Shanshan and Lin, Xiaoru and Zhao, Chuansheng and Li, Yugang},
  title = {Emerging Roles of Adenosine Metabolism in Astrocytes During Brain Injury},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {5},
  doi = {10.1002/cns.70889}
}
Kostenlos starten →